Fifth Third Wealth Advisors
WST icon

Fifth Third Wealth Advisors’s West Pharmaceutical WST Stock Holding History

Fifth Third Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$706K Buy
1,903
+631
+50% +$223K 0.02% 401
2026
Q2 		$457K Buy
1,272
+351
+38% +$107K 0.01% 527
2026
Q1 		$231K Buy
+921
New +$229K 0.01% 720
2025
Q1 		– Sell
-631
Closed -$207K – 756
2024
Q4 		$207K Buy
+631
New +$199K 0.01% 688
2024
Q3 		– Sell
-670
Closed -$221K – 733
2024
Q2 		$221K Buy
+670
New +$237K 0.02% 556

Other funds holding WST

Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
AMI Asset Management
AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return
Seilern Investment Management
Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
North Growth Management
North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fifth Third Wealth Advisors's WST Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its West Pharmaceutical (WST) stake by 50% in Q3 2026, buying an estimated $223K and bringing the position to 1,903 shares worth $706K. The position accounts for 0.02% of the portfolio, ranked #401.

Fifth Third Wealth Advisors first reported a position in WST in Q2 2024 and has held it in 5 quarters since. 175 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Fifth Third Wealth Advisors held 1,903 shares of West Pharmaceutical worth $706K as of Q3 2026.
  • Fifth Third Wealth Advisors bought 631 West Pharmaceutical shares in Q3 2026, an estimated $223K.
  • West Pharmaceutical made up 0.02% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #401 holding.
  • Fifth Third Wealth Advisors first reported a position in West Pharmaceutical in Q2 2024 and has held it in 5 quarters since.
  • 175 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.